Kristiina Iljin
Publications
- High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer (2016)
- Journal of Molecular Biochemistry
(A1 Refereed original research article in a scientific journal) - REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker (2016)
- PLoS ONE
(A1 Refereed original research article in a scientific journal) - Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions (2015)
- International Journal of Cancer
(A1 Refereed original research article in a scientific journal) - Characterization of Leukocyte Formin FMNL1 Expression in Human Tissues (2014)
- Journal of Histochemistry and Cytochemistry
(A1 Refereed original research article in a scientific journal) - Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients (2014)
- Oncotarget
(A1 Refereed original research article in a scientific journal) - FHOD1, a Formin Upregulated in Epithelial-Mesenchymal Transition, Participates in Cancer Cell Migration and Invasion (2013)
- PLoS ONE
(A1 Refereed original research article in a scientific journal) - High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion (2013)
- Oncotarget
(A1 Refereed original research article in a scientific journal) - Chemical Biology Drug Sensitivity Screen Identifies Sunitinib as Synergistic Agent with Disulfiram in Prostate Cancer Cells (2012)
- PLoS ONE
(A1 Refereed original research article in a scientific journal) - c-Jun N-Terminal Kinase Phosphorylation of MARCKSL1 Determines Actin Stability and Migration in Neurons and in Cancer Cells (2012)
- Molecular and Cellular Biology
(A1 Refereed original research article in a scientific journal) - High-throughout transriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer (2012)
- PLoS ONE
(A1 Refereed original research article in a scientific journal) - Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer (2012)
- Prostate
(A1 Refereed original research article in a scientific journal) - Interaction with ErbB4 promotes hypoxia-inducible factor-1α signaling (2012)
- Journal of Biological Chemistry
(A1 Refereed original research article in a scientific journal) - Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress (2012)
- British Journal of Cancer
(A1 Refereed original research article in a scientific journal) - Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer (2011)
- American Journal of Pathology
(A1 Refereed original research article in a scientific journal) - Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins (2011)
- Oncotarget
(A1 Refereed original research article in a scientific journal) - Characterization of Diaphanous-related formin FMNL2 in human tissues. (2010)
- BMC Cell Biology
(A1 Refereed original research article in a scientific journal) - FZD4 as a Mediator of ERG Oncogene-Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells (2010)
- Cancer Research
(A1 Refereed original research article in a scientific journal) - Integrative Functional Genomics Analysis of Sustained Polyploidy Phenotypes in Breast Cancer Cells Identifies an Oncogenic Profile for GINS2 (2010)
- Neoplasia
(A1 Refereed original research article in a scientific journal) - Monensin Is a Potent Inducer of Oxidative Stress and Inhibitor of Androgen Signaling Leading to Apoptosis in Prostate Cancer Cells (2010)
- Molecular Cancer Therapeutics
(A1 Refereed original research article in a scientific journal)